{"nct_id":"NCT02513186","title":"Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate Transplantation","status":"COMPLETED","status_verified_date":"2024-01","start_date":"2015-09-30","start_date_type":"ACTUAL","primary_completion_date":"2022-01-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-01-22","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["SNY"]}